Company intelligence / Profile preview

Tonghua Shenyuan Pharmaceutical

Tonghua, Jilin, China

Ownership: Private
Employees: ~1532
Development stage: Other

Overview

Tonghua Golden-Horse Pharmaceutical delivers a mix of traditional Chinese medicine, chemical drugs, and modern biopharmaceuticals; several products are approved (including for liver cancer and Alzheimer disease), with a pipeline focused on chronic disease and aging populations. Multiple products are commercialized in China[1][3][6].

Therapeutic areas: OncologyNeurologyWomen's HealthRheumatology
Modalities: Small moleculeHerbal medicineBiologic
Industry: Biotech

Drug pipeline

1 asset

xiaoaiping

Unknown

Beyond the preview

Go deeper on Tonghua Shenyuan Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tonghua Shenyuan Pharmaceutical.

Explore the full profile